Download the in-depth case study
Osteoarthritis affects around 30 million Americans, causing pain and severe disability. Unfortunately, there are few treatments. Many rely on over-the-counter analgesics to manage their pain. Some ultimately opt for joint replacement surgery.
To better help patients, OrthoTrophix is developing a peptide drug designed to regenerate cartilage. The company hopes this approach will restore function.
Download this article
Andexanet Alfa’s breakthrough designation added significant pressures to Portola’s planned clinical studies, accelerating their pace and putting added stresses on the clinical supply chain. This case study highlights the clinical supply challenges that come with the breakthrough-therapy designation, and offers a look at possible solutions.
Download this article in pdf format
Selecting appropriate clinical packaging and shipping strategies can be the difference between an efficient clinical supply chain, or an expensive fiasco. This case study details how Sherpa Clinical Packaging partnered with South Bay Therapeutics* to craft the best clinical supply management strategies for their multiple, complex clinical trials.